Biden's choice for FDA may be a wild card as top candidate says she's not in the running
President Biden told reporters yesterday that he’s close to nominating someone to be the next FDA commissioner, but it still remains unclear who he might select.
With a little more than a month to make his nomination, experts and Politico pointed yesterday to Dana-Farber Cancer Institute CEO Laurie Glimcher as a top candidate, given her leadership position and drug development experience.
But Glimcher, an immunologist by training who also serves on GlaxoSmithKline’s board, told Endpoints News via email on Thursday: “I am committed to Dana-Farber Cancer institute and our ongoing progress against cancer, and I am not a candidate to be the next commissioner of the FDA.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 128,800+ biopharma pros reading Endpoints daily — and it's free.